Lista de obras - Antje Sucker - Dominio Público Uruguay

A multimarker prognostic assay for primary cutaneous melanoma

artículo científico publicado en 2009

Acquired IFNγ resistance impairs anti-tumor immunity and gives rise to T-cell-resistant melanoma lesions

artículo científico publicado en 2017

An inherited variant in the gene coding for vitamin D-binding protein and survival from cutaneous melanoma: a BioGenoMEL study

artículo científico publicado en 2013

Analysis of SDHD promoter mutations in various types of melanoma

artículo científico publicado en 2015

Angiopoietin-2 levels are associated with disease progression in metastatic malignant melanoma

artículo científico publicado en 2009

Assessing quality and functionality of DNA isolated from FFPE tissues through external quality assessment in tissue banks

artículo científico publicado en 2015

Association between the germline MC1R variants and somatic BRAF/NRAS mutations in melanoma tumors

artículo científico publicado en 2010

Association of inherited variation in Toll-like receptor genes with malignant melanoma susceptibility and survival

artículo científico publicado en 2011

Atypical fibroxanthoma and pleomorphic dermal sarcoma harbor frequent NOTCH1/2 and FAT1 mutations and similar DNA copy number alteration profiles

artículo científico publicado en 2017

Atypical melanocytic proliferations and new primary melanomas in patients with advanced melanoma undergoing selective BRAF inhibition

artículo científico publicado en 2012

B-RAF and N-RAS mutations are preserved during short time in vitro propagation and differentially impact prognosis

artículo científico publicado en 2007

Baseline Peripheral Blood Biomarkers Associated with Clinical Outcome of Advanced Melanoma Patients Treated with Ipilimumab

artículo científico publicado en 2016

Circulating CD4+ T cells that produce IL4 or IL17 when stimulated by melan-A but not by NY-ESO-1 have negative impacts on survival of patients with stage IV melanoma

artículo científico publicado en 2014

Complete loss of HLA class I antigen expression on melanoma cells: a result of successive mutational events

artículo científico publicado en 2003

Conjunctival melanomas harbor BRAF and NRAS mutations and copy number changes similar to cutaneous and mucosal melanomas

artículo científico publicado en 2013

Deciphering the genetic evolution of T-cell resistance in melanoma

artículo científico publicado en 2015

Diagnosing a Primary Leptomeningeal Melanoma by Gene Mutation Signature

artículo científico publicado en 2016

Differential clinical significance of individual NKG2D ligands in melanoma: soluble ULBP2 as an indicator of poor prognosis superior to S100B.

artículo científico publicado en 2009

Frequent GNAQ, GNA11, and EIF1AX Mutations in Iris Melanoma

artículo científico publicado en 2017

Frequent TERT Promoter Mutations in Ocular Surface Squamous Neoplasia

artículo científico publicado en 2015

Fulminant response to combined checkpoint inhibition with ipilimumab plus nivolumab after failure of nivolumab monotherapy in metastatic melanoma

Genetic and clinico-pathologic analysis of metastatic uveal melanoma

artículo científico publicado en 2013

Genetic evolution of T-cell resistance in the course of melanoma progression

artículo científico publicado en 2014

Genomic correlates of response to CTLA-4 blockade in metastatic melanoma

artículo científico publicado en 2015

Increases in Absolute Lymphocytes and Circulating CD4+ and CD8+ T Cells Are Associated with Positive Clinical Outcome of Melanoma Patients Treated with Ipilimumab

artículo científico publicado en 2016

Independent replication of a melanoma subtype gene signature and evaluation of its prognostic value and biological correlates in a population cohort ⬇️

artículo científico publicado en 2015

Influence of genetic variants in type I interferon genes on melanoma survival and therapy

artículo científico publicado en 2012

Inherited functional variants of the lymphocyte receptor CD5 influence melanoma survival

artículo científico publicado en 2016

Inherited variants in the MC1R gene and survival from cutaneous melanoma: a BioGenoMEL study

artículo científico publicado en 2012

Inherited variation in the PARP1 gene and survival from melanoma

artículo científico publicado en 2014

Integrin genes and susceptibility to human melanoma

artículo científico publicado en 2011

Interferon-gamma down-regulates NKG2D ligand expression and impairs the NKG2D-mediated cytolysis of MHC class I-deficient melanoma by natural killer cells

artículo científico publicado en 2009

Intraventricular melanocytoma diagnosis confirmed by gene mutation profile

artículo científico publicado en 2017

Is there a role for immune checkpoint blockade in metastatic uveal melanoma?

Lack of SF3B1 R625 mutations in cutaneous melanoma

artículo científico publicado en 2013

Liquid Profiling of Circulating Tumor DNA in Plasma of Melanoma Patients for Companion Diagnostics and Monitoring of BRAF Inhibitor Therapy

artículo científico publicado en 2018

Mapping of deletion breakpoints at the CDKN2A locus in melanoma: detection of MTAP-ANRIL fusion transcripts

artículo científico publicado en 2016

Melanoma Lesions Independently Acquire T-cell Resistance during Metastatic Latency

artículo científico publicado en 2016

Melanoma genome sequencing reveals frequent PREX2 mutations

artículo científico publicado en 2012

Metalloprotease-mediated tumor cell shedding of B7-H6, the ligand of the natural killer cell-activating receptor NKp30.

artículo científico publicado en 2014

Metastatic potential of melanomas defined by specific gene expression profiles with no BRAF signature

artículo científico publicado en 2006

Myeloid Cells and Related Chronic Inflammatory Factors as Novel Predictive Markers in Melanoma Treatment with Ipilimumab

artículo científico publicado en 2015

Myeloid-derived suppressor cells predict survival of patients with advanced melanoma: comparison with regulatory T cells and NY-ESO-1- or melan-A-specific T cells

artículo científico publicado en 2013

PD-L1 status does not predict the outcome of BRAF inhibitor therapy in metastatic melanoma

artículo científico publicado en 2017

Phenotypic characterization and prognostic impact of circulating γδ and αβ T-cells in metastatic malignant melanoma

artículo científico publicado en 2015

RAS mutations are associated with the development of cutaneous squamous cell tumors in patients treated with RAF inhibitors

artículo científico publicado en 2011

SERPINB1 expression is predictive for sensitivity and outcome of cisplatin-based chemotherapy in melanoma

artículo científico publicado en 2016

SF3B1 and BAP1 mutations in blue nevus-like melanoma

artículo científico publicado en 2017

STAT3 Single Nucleotide Polymorphism rs4796793 SNP Does Not Correlate with Response to Adjuvant IFNα Therapy in Stage III Melanoma Patients

artículo científico publicado en 2014

STAT5 expression correlates with recurrence and survival in melanoma patients treated with interferon-α.

artículo científico publicado en 2018

Single-strand DNA library preparation improves sequencing of formalin-fixed and paraffin-embedded (FFPE) cancer DNA

artículo científico publicado en 2016

Somatic alterations in the melanoma genome: a high-resolution array-based comparative genomic hybridization study

artículo científico publicado en 2010

TERT promoter mutation status as an independent prognostic factor in cutaneous melanoma

artículo científico publicado en 2014

TERT promoter mutations are frequent in atypical fibroxanthomas and pleomorphic dermal sarcomas

artículo científico publicado en 2013

TERT promoter mutations are frequent in cutaneous basal cell carcinoma and squamous cell carcinoma

artículo científico publicado en 2013

Targeted next generation sequencing of mucosal melanomas identifies frequent NF1 and RAS mutations

artículo científico publicado en 2017

The coincidence of chromosome 15 aberrations and beta2-microglobulin gene mutations is causative for the total loss of human leukocyte antigen class I expression in melanoma

artículo científico publicado en 2006

The genetic landscape of clinical resistance to RAF inhibition in metastatic melanoma

artículo científico publicado en 2013

The proteasome immunosubunits, PA28 and ER-aminopeptidase 1 protect melanoma cells from efficient MART-126-35 -specific T-cell recognition

artículo científico publicado en 2015

Tumor CDKN2A-Associated JAK2 Loss and Susceptibility to Immunotherapy Resistance

artículo científico publicado en 2018

Tumor type M2 pyruvate kinase (TuM2-PK) as a novel plasma tumor marker in melanoma

artículo científico publicado en 2005

Vemurafenib reverses immunosuppression by myeloid derived suppressor cells

artículo científico publicado en 2013

pHH3 immunostaining improves interobserver agreement of mitotic index in thin melanomas

artículo científico publicado en 2012

Lista de obras de Antje Sucker

A multimarker prognostic assay for primary cutaneous melanoma

Acquired IFNγ resistance impairs anti-tumor immunity and gives rise to T-cell-resistant melanoma lesions

An inherited variant in the gene coding for vitamin D-binding protein and survival from cutaneous melanoma: a BioGenoMEL study

Analysis of SDHD promoter mutations in various types of melanoma

Angiopoietin-2 levels are associated with disease progression in metastatic malignant melanoma

Assessing quality and functionality of DNA isolated from FFPE tissues through external quality assessment in tissue banks

Association between the germline MC1R variants and somatic BRAF/NRAS mutations in melanoma tumors

Association of inherited variation in Toll-like receptor genes with malignant melanoma susceptibility and survival

Atypical fibroxanthoma and pleomorphic dermal sarcoma harbor frequent NOTCH1/2 and FAT1 mutations and similar DNA copy number alteration profiles

Atypical melanocytic proliferations and new primary melanomas in patients with advanced melanoma undergoing selective BRAF inhibition

B-RAF and N-RAS mutations are preserved during short time in vitro propagation and differentially impact prognosis

Baseline Peripheral Blood Biomarkers Associated with Clinical Outcome of Advanced Melanoma Patients Treated with Ipilimumab

Circulating CD4+ T cells that produce IL4 or IL17 when stimulated by melan-A but not by NY-ESO-1 have negative impacts on survival of patients with stage IV melanoma

Complete loss of HLA class I antigen expression on melanoma cells: a result of successive mutational events

Conjunctival melanomas harbor BRAF and NRAS mutations and copy number changes similar to cutaneous and mucosal melanomas

Deciphering the genetic evolution of T-cell resistance in melanoma

Diagnosing a Primary Leptomeningeal Melanoma by Gene Mutation Signature

Differential clinical significance of individual NKG2D ligands in melanoma: soluble ULBP2 as an indicator of poor prognosis superior to S100B.

Frequent GNAQ, GNA11, and EIF1AX Mutations in Iris Melanoma

Frequent TERT Promoter Mutations in Ocular Surface Squamous Neoplasia

Fulminant response to combined checkpoint inhibition with ipilimumab plus nivolumab after failure of nivolumab monotherapy in metastatic melanoma

Genetic and clinico-pathologic analysis of metastatic uveal melanoma

Genetic evolution of T-cell resistance in the course of melanoma progression

Genomic correlates of response to CTLA-4 blockade in metastatic melanoma

Increases in Absolute Lymphocytes and Circulating CD4+ and CD8+ T Cells Are Associated with Positive Clinical Outcome of Melanoma Patients Treated with Ipilimumab

Independent replication of a melanoma subtype gene signature and evaluation of its prognostic value and biological correlates in a population cohort ⬇️

Influence of genetic variants in type I interferon genes on melanoma survival and therapy

Inherited functional variants of the lymphocyte receptor CD5 influence melanoma survival

Inherited variants in the MC1R gene and survival from cutaneous melanoma: a BioGenoMEL study

Inherited variation in the PARP1 gene and survival from melanoma

Integrin genes and susceptibility to human melanoma

Interferon-gamma down-regulates NKG2D ligand expression and impairs the NKG2D-mediated cytolysis of MHC class I-deficient melanoma by natural killer cells

Intraventricular melanocytoma diagnosis confirmed by gene mutation profile

Is there a role for immune checkpoint blockade in metastatic uveal melanoma?

Lack of SF3B1 R625 mutations in cutaneous melanoma

Liquid Profiling of Circulating Tumor DNA in Plasma of Melanoma Patients for Companion Diagnostics and Monitoring of BRAF Inhibitor Therapy

Mapping of deletion breakpoints at the CDKN2A locus in melanoma: detection of MTAP-ANRIL fusion transcripts

Melanoma Lesions Independently Acquire T-cell Resistance during Metastatic Latency

Melanoma genome sequencing reveals frequent PREX2 mutations

Metalloprotease-mediated tumor cell shedding of B7-H6, the ligand of the natural killer cell-activating receptor NKp30.

Metastatic potential of melanomas defined by specific gene expression profiles with no BRAF signature

Myeloid Cells and Related Chronic Inflammatory Factors as Novel Predictive Markers in Melanoma Treatment with Ipilimumab

Myeloid-derived suppressor cells predict survival of patients with advanced melanoma: comparison with regulatory T cells and NY-ESO-1- or melan-A-specific T cells

PD-L1 status does not predict the outcome of BRAF inhibitor therapy in metastatic melanoma

Phenotypic characterization and prognostic impact of circulating γδ and αβ T-cells in metastatic malignant melanoma

RAS mutations are associated with the development of cutaneous squamous cell tumors in patients treated with RAF inhibitors

SERPINB1 expression is predictive for sensitivity and outcome of cisplatin-based chemotherapy in melanoma

SF3B1 and BAP1 mutations in blue nevus-like melanoma

STAT3 Single Nucleotide Polymorphism rs4796793 SNP Does Not Correlate with Response to Adjuvant IFNα Therapy in Stage III Melanoma Patients

STAT5 expression correlates with recurrence and survival in melanoma patients treated with interferon-α.

Single-strand DNA library preparation improves sequencing of formalin-fixed and paraffin-embedded (FFPE) cancer DNA

Somatic alterations in the melanoma genome: a high-resolution array-based comparative genomic hybridization study

TERT promoter mutation status as an independent prognostic factor in cutaneous melanoma

TERT promoter mutations are frequent in atypical fibroxanthomas and pleomorphic dermal sarcomas

TERT promoter mutations are frequent in cutaneous basal cell carcinoma and squamous cell carcinoma

Targeted next generation sequencing of mucosal melanomas identifies frequent NF1 and RAS mutations

The coincidence of chromosome 15 aberrations and beta2-microglobulin gene mutations is causative for the total loss of human leukocyte antigen class I expression in melanoma

The genetic landscape of clinical resistance to RAF inhibition in metastatic melanoma

The proteasome immunosubunits, PA28 and ER-aminopeptidase 1 protect melanoma cells from efficient MART-126-35 -specific T-cell recognition

Tumor CDKN2A-Associated JAK2 Loss and Susceptibility to Immunotherapy Resistance

Tumor type M2 pyruvate kinase (TuM2-PK) as a novel plasma tumor marker in melanoma

Vemurafenib reverses immunosuppression by myeloid derived suppressor cells

pHH3 immunostaining improves interobserver agreement of mitotic index in thin melanomas